At the news
? NEUTRALIMPACT 3/10 SC 13G filed Nov 10, 2026 at 08:50 ET
State Street Corporation filed a Schedule 13G disclosing a passive 5.4% beneficial ownership stake in Novavax as of September 30, 2026. This is a new 13G filing for State Street on NVAX, adding to a series of prior passive filings by other institutional holders. The filing indicates no intent to influence control, consistent with State Street's role as an index fund manager.
- State Street Corp filed a new Schedule 13G disclosing beneficial ownership of 8,827,707 shares of Novavax common stock.
- The stake represents 5.4% of shares outstanding as of September 30, 2026.
- State Street certifies the shares were acquired in the ordinary course of business and not with the purpose of changing or influencing control.
- State Street is a large index fund manager (State Street Global Advisors), making this a routine passive disclosure.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access